Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy 　- An Observational Pharmacy Claims Database Study.

CONCLUSIONS: Age, concomitant use of certain classes of medications (or the existence of these diseases) and secondary prevention were associated with adherence and persistence of statin-ezetimibe combinational LLT. Given that dyslipidemia is a chronic disease requiring life-long control, active interventions are required for patients with poor adherence and persistence. PMID: 31281135 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31281135?dopt=Abstract

Source: Circulation Journal - July 4, 2019 Category: Cardiology Authors: Umeda T, Hayashi A, Fujimoto G, Piao Y, Matsui N, Tokita S Tags: Circ J Source Type: research

Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy - An Observational Pharmacy Claims Database Study.

Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy 　- An Observational Pharmacy Claims Database Study.